Association between cytochrome P450 2C19 681G>A polymorphisms and risk of cardiovascular events in coronary heart disease with clopidogrel in Chinese

被引：0
|
作者：
Yuan, J. [1 ]
Tang, X. F. [1 ]
Yang, Y. J. [1 ]
Gao, R. L. [1 ]
机构：
[1] Cardiovasc Inst & Fuwai Hosp, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [31] Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
    Jin, Bo
    Ni, Huan-Chun
    Shen, Wei
    Li, Jian
    Shi, Hai-Ming
    Li, Yong
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (03) : 1697 - 1702
  • [32] Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    F Sofi
    B Giusti
    R Marcucci
    A M Gori
    R Abbate
    G F Gensini
    The Pharmacogenomics Journal, 2011, 11 : 199 - 206
  • [33] Cytochrome P450 2C19☆2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
    Sofi, F.
    Giusti, B.
    Marcucci, R.
    Gori, A. M.
    Abbate, R.
    Gensini, G. F.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (03): : 199 - 206
  • [34] Cytochrome P450 2C19 polymorphism and cardiovascular recurrences in patients under clopidogrel treatment: a meta-analysis
    Sofi, F.
    Giusti, B.
    Gori, A.
    Marcucci, R.
    Abbate, R.
    Gensini, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 105 - 105
  • [35] Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness
    Fontana, Pierre
    Senouf, David
    Mach, Francois
    THROMBOSIS RESEARCH, 2008, 121 (04) : 463 - 468
  • [36] The Pharmacogenetics of Cytochrome P450 2C19 enzymes - Effects on Clopidogrel and Proton Pump Inhibitors
    Liau, Yusmiati
    Muliaty, Dewi
    INDONESIAN BIOMEDICAL JOURNAL, 2014, 6 (01): : 33 - 44
  • [37] Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
    Yu, Luhai
    Wang, Tingting
    Bai, Huidong
    Zhu, Weijiang
    Li, Yanju
    Wu, Jianhua
    Liu, Wenli
    Sun, Li
    Yu, Aiping
    Li, Hongjian
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [38] Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
    Luhai Yu
    Tingting Wang
    Huidong Bai
    Weijiang Zhu
    Yanju Li
    Jianhua Wu
    Wenli Liu
    Li Sun
    Aiping Yu
    Hongjian Li
    BMC Cardiovascular Disorders, 21
  • [39] Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
    Kreutz, Rolf P.
    Nystrom, Perry
    Kreutz, Yvonne
    Miao, Jia
    Desta, Zeruesenay
    Breall, Jeffrey A.
    Li, Lang
    Chiang, ChienWei
    Kovacs, Richard
    Flockhart, David A.
    Jin, Yan
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2012, 4 : 13 - 20
  • [40] ASSOCIATION OF BREAST CANCER WITH CYTOCHROME P450 2C19 GENETICS - RISK AND RESPONSE TO ADJUVANT THERAPY
    Cavaco, Isa
    Edvardsen, Hege
    Ingelman-Sundberg, Magnus
    Kristensen, Vessela
    Sim, Sarah
    DRUG METABOLISM REVIEWS, 2014, 45 : 210 - 210
12345